NASDAQ:DARA - DARA Biosciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.30 0.00 (0.00 %)
(As of 11/16/2018 04:00 PM ET)
Previous Close$0.30
Today's Range$0.30 - $0.30
52-Week Range$0.67 - $1.05
VolumeN/A
Average Volume118,843 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
DARA BioSciences Inc is specialty pharmaceutical company based in the United States. The Company's primary focus is on the commercialization of oncology treatment and oncology supportive care pharmaceutical products, including Soltamox, an oral solution of tamoxifen citrate; cancer support therapeutics, including Gelclair, indicated for the treatment of oral mucositis and Bionect, for the management of irritation of the skin as well as first and second degree burns, and Three Mission Pharmacal products, including Ferralet 90 (for anemia), Binosto (alendronate sodium effervescent tablet indicated for the treatment of osteoporosis) and Aquoral (for cancer related dry mouth). The Company has a clinical development asset, KRN5500, which is a Phase II product candidate targeted for treating cancer patients with painful treatment-refractory chronic chemotherapy induced peripheral neuropathy. The Company is a subsidiary of Midatech Pharma Plc.

Receive DARA News and Ratings via Email

Sign-up to receive the latest news and ratings for DARA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:DARA
Previous Symbol
CUSIPN/A
Phone+1-816-9147027

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

DARA Biosciences (NASDAQ:DARA) Frequently Asked Questions

What is DARA Biosciences' stock symbol?

DARA Biosciences trades on the NASDAQ under the ticker symbol "DARA."

How were DARA Biosciences' earnings last quarter?

DARA Biosciences Inc (NASDAQ:DARA) issued its earnings results on Monday, November, 2nd. The specialty pharmaceutical company reported ($0.14) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.14). The specialty pharmaceutical company earned $1.18 million during the quarter, compared to analyst estimates of $0.83 million. View DARA Biosciences' Earnings History.

Has DARA Biosciences been receiving favorable news coverage?

News headlines about DARA stock have trended negative recently, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. DARA Biosciences earned a media sentiment score of -2.6 on InfoTrie's scale. They also assigned media headlines about the specialty pharmaceutical company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days.

How do I buy shares of DARA Biosciences?

Shares of DARA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DARA Biosciences' stock price today?

One share of DARA stock can currently be purchased for approximately $0.30.

What is DARA Biosciences' official website?

The official website for DARA Biosciences is http://www.darabiosciences.com/.

How can I contact DARA Biosciences?

DARA Biosciences' mailing address is 8601 Six Forks Rd Ste 160, RALEIGH, NC 27615-2965, United States. The specialty pharmaceutical company can be reached via phone at +1-816-9147027.


MarketBeat Community Rating for DARA Biosciences (NASDAQ DARA)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  86 (Vote Outperform)
Underperform Votes:  63 (Vote Underperform)
Total Votes:  149
MarketBeat's community ratings are surveys of what our community members think about DARA Biosciences and other stocks. Vote "Outperform" if you believe DARA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DARA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel